MERS-CoV

Middle East respiratory syndrome coronavirus (MERS-CoV) is an emerging zoonotic coronavirus. First identified in 2012, MERS-CoV has caused over 2460 infections and a fatality rate of about 35% in humans. Similar to severe acute respiratory syndrome coronavirus (SARS-CoV), MERS-CoV likely originated...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Du, Lanying, Li, Fang
Formato: Livro
Lenguaje:Inglês
Publicado: MDPI - Multidisciplinary Digital Publishing Institute 2019
Materias:
QH301-705.5
Q1-390
thema EDItEUR::P Mathematics and Science::PS Biology, life sciences
cell–cell fusion
hDPP4
n/a
therapeutics
animal models
HCoV-229E
Drivers
camels
rabbits
SARS-CoV
MERS-CoV
MVA vaccine
transmission
RBD
MERS-CoV nucleocapsid protein
complement
animal model
pseudotyped virus
combination
MERS-coronavirus
peptide
mouse model
spike protein
receptor-binding domain
prevention and treatment
coronaviruses
coronavirus spike glycoprotein
therapeutic antibodies
vaccine platforms
mutation
severe acute respiratory syndrome coronavirus
pathogenesis
fusion inhibitor
Coronavirus
murine CD8+ T cell epitope
lipidomics
authentic virus
correlates of immunity
vaccines
neutralizing monoclonal antibodies
Middle East respiratory syndrome coronavirus
small-molecule inhibitor
Middle East Respiratory Syndrome Virus
DPP4
pyroptosis
cross-neutralization
inflammation
Qatar
spike proteins
One Health
HKU4
nanobodies
mechanism of action
neutralizing antibody
host factors
UHPLC–MS
Acceso en línea:https://directory.doabooks.org/handle/20.500.12854/53201
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares